Cancer patients monitored for years after revolutionary cell therapy
Disease control
ENROLLING_BY_INVITATION
This study follows patients who previously received AvenCell's CAR-T cell therapy in earlier clinical trials. Researchers want to understand the long-term safety and effectiveness of these cancer treatments over time. The study will track 178 patients with various blood cancers a…
Sponsor: AvenCell Therapeutics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC